Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

[Involvement of dynamic HBeAg quantitation and response during chronic hepatitis B treatment].

Lun XY.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012 Aug;26(4):295-7. Chinese.

PMID:
23189849
2.

[Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].

Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.

Zhonghua Yi Xue Za Zhi. 2007 Jul 10;87(26):1840-3. Chinese.

PMID:
17922996
3.

Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B.

Heijtink RA, Kruining J, Honkoop P, Kuhns MC, Hop WC, Osterhaus AD, Schalm SW.

J Med Virol. 1997 Nov;53(3):282-7.

PMID:
9365897
4.

Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.

van der Eijk AA, Niesters HG, Hansen BE, Heijtink RA, Janssen HL, Schalm SW, de Man RA.

J Viral Hepat. 2006 Feb;13(2):96-103.

PMID:
16436127
5.

[Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].

Lu H, Ma LX, Xu WS, Zhang HY, Yu LJ, Duan HY.

Zhonghua Gan Zang Bing Za Zhi. 2003 Mar;11(3):173-5. Chinese.

PMID:
12681068
6.

Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.

Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.

Am J Gastroenterol. 2005 Nov;100(11):2463-71.

PMID:
16279901
7.

Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.

Akhan SC, Yulugkural Z, Vahaboglu H.

Chemotherapy. 2007;53(6):402-6. Epub 2007 Oct 12.

PMID:
17934260
8.

[A multicenter study of the effectiveness of interferon alpha-1b (Hapgen) in treating HBeAg positive chronic hepatitis B patients].

Jin R, Guo XH, Huang JF, Liu Z, Li HW, Wang ZB, Zhang B, Xie YM.

Zhonghua Gan Zang Bing Za Zhi. 2011 Jan;19(1):25-8. doi: 10.3760/cma.j.issn.1007-3418.2011.01.008. Chinese.

PMID:
21272454
9.

[The relationship between HBV genotypes and the efficacy of antiviral therapies in hepatitis B e antigen- positive patients].

Zou HB, Zhu LM, Zhao GM, Liang SR, Li J, Lu CZ, Li H.

Zhonghua Gan Zang Bing Za Zhi. 2007 Jun;15(6):425-7. Chinese.

PMID:
17594806
10.

Interferon treatment with or without oral ganciclovir in HBeAg-negative chronic hepatitis B: a randomized study.

Hadziyannis S, Alexopoulou A, Papakonstantinou A, Petraki K, Manesis E.

J Viral Hepat. 2000 May;7(3):235-40.

PMID:
10849267
11.

Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.

Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.

J Med Virol. 2007 Sep;79(9):1286-92.

PMID:
17607775
12.

Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.

Idilman R, Cinar K, Seven G, Bozkus Y, Elhan A, Bozdayi M, Yurdaydin C, Bahar K.

J Viral Hepat. 2012 Mar;19(3):220-6. doi: 10.1111/j.1365-2893.2011.01542.x. Epub 2011 Oct 19.

PMID:
22329377
13.

Multicenter retrospective study of response to interferon in chronic hepatitis B.

Martín-Vivaldi R, Nogueras F, Vignote ML, Salmerón J, Aguilar J, Romero M, Andrade R, De la Mata M, Moreno JM, Pérez J, García G, López de Hierro M, Gómez F, Palacios A, Otero S, Suárez E, Poyatos A, Quintero D.

Rev Esp Enferm Dig. 2000 Sep;92(9):561-72. English, Spanish.

PMID:
11138238
14.

Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.

Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.

Int J Mol Med. 2002 Aug;10(2):201-4.

PMID:
12119559
15.

[Factors related to chronic hepatitis B relapse after interferon-alpha treatment: a follow-up study].

Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Aug;27(8):1264-6, 1270. Chinese.

16.

Simultaneous quantitation of serum HBV DNA and HBeAg can distinguish between slow and fast viral responses to antiviral therapy in patients with chronic hepatitis B.

da Silva LC, Nova ML, Ono-Nita SK, Pinho JR, Sitnik R, Santos VA, Carrilho FJ.

Rev Inst Med Trop Sao Paulo. 2009 Sep-Oct;51(5):261-8.

17.
18.

Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B.

Alexopoulou A, Owsianka AM, Kafiri G, Dourakis SP, Carman WF, Hadziyannis SJ.

J Hepatol. 1998 Sep;29(3):345-51.

PMID:
9764979
19.

[A reduction study of seroconversion of HBsAg in chronic hepatitis B patients with HBeAg positive by combination treatment with interferon and lamivudine].

Yu SL, Qin LY, Wang C, Yu LJ, Guo CY, Wang YZ.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jun;17(6):472-3. Chinese. No abstract available.

PMID:
19567034
20.

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL.

Hepatology. 2004 Mar;39(3):804-10.

PMID:
14999700

Supplemental Content

Support Center